Abstract
Uveal melanoma is the most common condition of the eye that is treated with radiation therapy. While there are several modalities that are available to treat uveal melanoma, proton beam therapy is an ideal treatment for properly selected patients because of steeper dose falloff and less dose to normal tissues with proton beam therapy compared with photons. Thousands of patients have been safely and effectively treated with proton beam therapy for uveal melanoma. Other conditions in the eye that have been managed with proton beam therapy include retinoblastoma, orbital rhabdomyosarcoma, and optic pathway glioma. More research on these indications is needed to realize the full potential of proton beam therapy for conditions of the eye.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Delaney T, Kooy H. Proton and charged particle radiotherapy. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 154.
Höcht S, Stark R, Seiler F, et al. Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison. Strahlenther Onkol. 2005;181(12):783–8.
Weber DC, Bogner J, Verwey J, et al. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: a comparative study. Int J Radiat Oncol Biol Phys. 2005;63(2):373–84.
Muller K, Nowak PJ, Naus N, et al. Lacrimal gland radiosensitivity in uveal melanoma patients. Int J Radiat Oncol Biol Phys. 2009;74(2):497–502.
Newhauser WD, Koch NC, Fontenot JD, et al. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy. Phys Med Biol. 2007;52(13):3979–90.
Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124(12):1684–93.
Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based Âestimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002;120(12):1665–71.
Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys. 2006;65(3):780–7.
Caujolle JP, Mammar H, Chamorey E, Pinon F, Herault J, Gastaud P. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years’ experience. Int J Radiat Oncol Biol Phys. 2010;78(1):98–103.
Gragoudas ES, Lane AM, Regan S, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000;118(6):773–8.
Marucci L, Ancukiewicz M, Lane AM, Collier JM, Gragoudas ES, Munzenrider JE. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. Int J Radiat Oncol Biol Phys. 2011;79(3):842–6.
Chang JW, Yu YS, Kim JY, et al. The clinical outcomes of proton beam radiation therapy for retinoblastomas that were resistant to chemotherapy and focal treatment. Korean J Ophthalmol. 2011;25(6):387–93.
Hug EB, Adams J, Fitzek M, De Vries A, Munzenrider JE. Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys. 2000;47(4):979–84.
Yock T, Schneider R, Friedmann A, Adams J, Fullerton B, Tarbell N. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys. 2005;63(4):1161–8.
Fuss M, Hug EB, Schaefer RA, et al. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys. 1999;45(5):1117–26.
Park SS, Daftari I, Phillips T, Morse LS. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration. Retina. 2012;32(5):956–66.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yajnik, S. (2013). Proton Therapy for Conditions of the Eye. In: Proton Beam Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5298-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5298-0_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5297-3
Online ISBN: 978-1-4614-5298-0
eBook Packages: MedicineMedicine (R0)